Tix Corporation (TIXC) 2.2400 $TIXC Tix Corporation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tix Corporation (TIXC) 2.2400 $TIXC

Tix Corporation Reports First Quarter 2016 Results
Marketwire Canada - Tue May 10, 7:01AM CDT
STUDIO CITY, CA--(Marketwired - May 10, 2016) - Tix Corporation (the "Company" (OTCQX: TIXC), a leading provider of discount ticketing services, today reported results for the first quarter ended March 31, 2016. 

Tix Corporation's Tix4Tonight Enters Into Agreement With Expedia Local Expert
Marketwire Canada - Thu May 05, 7:00AM CDT
STUDIO CITY, CA--(Marketwired - May 5, 2016) - Tix Corporation (the "Company" (OTCQX: TIXC), a leading provider of discount ticketing services, today announced that its Tix4Tonight, LLC subsidiary has entered into an agreement with Expedia LX Partner Business, Inc., doing business as Expedia Local Expert, a division of Expedia, Inc. (NASDAQ: EXPE), one of the world's largest online travel agencies. 
EXPE: 109.43 (+1.86)

Tix Corporation Increases Quarterly Cash Dividend by 10%
Marketwired - Mon Apr 04, 8:00AM CDT
The Board of Directors of Tix Corporation (OTCQX: TIXC), a leading provider of discount ticketing services, has authorized the increase of the Company's quarterly cash dividend by 10% to $0.055 per share, which represents an annualized rate of $0.22 per common share. The quarterly cash dividend will be paid on April 29, 2016 to all stockholders of record as of April 15, 2016.

Tix Corporation Maintains $0.05 Per Share Quarterly Cash Dividend for the Fiscal First Quarter 2016
Marketwired - Tue Jan 05, 8:01AM CST
The board of directors of Tix Corporation (OTCQX: TIXC), a leading provider of discount ticketing services, has maintained the company's regular quarterly cash dividend of $0.05 per share. The cash dividend will be paid on January 29, 2016 to all stockholders of record as of January 15, 2016.

Tix Corporation Reports Third Quarter and First Nine Months 2015 Results
Marketwired - Mon Oct 26, 8:00AM CDT
Tix Corporation (the "Company" (OTCQX: TIXC), a leading provider of discount ticketing services, today reported results for the third quarter and first nine months ended September 30, 2015.

Tix Corporation Maintains $0.05 per Share Quarterly Cash Dividend for the Fiscal Fourth Quarter 2015
Marketwired - Mon Oct 05, 8:00AM CDT
The board of directors of Tix Corporation (OTCQX: TIXC), a leading provider of discount ticketing services, has maintained the company's regular quarterly cash dividend of $0.05 per share. The cash dividend will be paid on October 30, 2015 to all stockholders of record as of October 16, 2015.

Tix Corporation Reports Second Quarter and First Six Months 2015 Results
Marketwired - Mon Jul 27, 8:01AM CDT
Tix Corporation (the "Company" (OTCQX: TIXC), a leading provider of discount ticketing services, today reported results for the second quarter and first six months ended June 30, 2015.

Tix Corporation Announces Annual Meeting Date
Marketwired - Thu Jul 16, 8:00AM CDT
Tix Corporation (the "Company" (OTCQX: TIXC), a leading provider of discount ticketing services, today announced that its 2015 annual meeting of stockholders (the "Annual Meeting" will be held at 10:00 A.M., local time, on August 28, 2015, at Sportsmen's Lodge Events Center, 12833 Ventura Boulevard, Studio City, California 91604. Stockholders of record as of the close of business on July 17, 2015, will be entitled to notice of and to vote at the Annual Meeting or any adjournments or postponements thereof.

Tix Corporation Announces Quarterly Cash Dividend
Marketwired - Mon Jul 06, 8:00AM CDT
Tix Corporation (OTCQX: TIXC), a leading provider of discount ticketing services, today announced that its Board of Directors, as part of Tix Corporation's previously announced quarterly cash dividend program, has declared a quarterly cash dividend of $0.05 per common share, which represents an annualized rate of $0.20 per common share. Shareholders of record as of July 16, 2015 will be paid the $0.05 per common share on July 30, 2015.

Tix Corporation Announces Quarterly Dividend Program
Marketwired - Wed Apr 01, 6:00AM CDT
Tix Corporation (the "Company" or "we" (OTCQX: TIXC), a leading provider of discount ticketing services, today announced its Board of Directors (the "Board" approved a program of paying a regular quarterly cash dividend to the Company's stockholders. The Board declared an initial quarterly cash dividend of $0.05 per common share to be paid on April 30, 2015 to stockholders of record as of the close of business on April 16, 2015. This quarterly dividend equates to $0.20 per share annually.

Tix Corporation Reports Fourth Quarter and Full Year 2014 Results
Marketwired - Tue Mar 31, 3:01PM CDT
Tix Corporation (the "Company" (OTCQX: TIXC)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 17

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 311

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 35

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading